CRISPR Therapeutics AG (CRSP) NASDAQ
52.02
-2.17(-4.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
52.02
-2.17(-4.00%)
Currency In USD
| Market Cap | 4.72B |
| Enterprise Value | 4.76B |
| P/E Ratio | -8.79 |
| PEG Ratio | 0.27 |
| Price/Sales Ratio | 1,222.83 |
| Price/Book Ratio | 2.75 |
| Enterprise/Revenue | 1,311.63 |
| Enterprise/EBITDA | -10.66 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -138.57 |
| Operating Margin | -134.08 |
| Return On Assets | -0.21 |
| Return On Equity | -0.31 |
| Revenue | 3.51M |
| Revenue/Share | 0.04 |
| Gross Profit | -229.45M |
| EBITDA | -548.84M |
| Net Income | -581.6M |
| Diluted EPS | -6.47 |
| Total Cash | 2.44B |
| Total Cash/Share | 25.42 |
| Total Debt | 787.64M |
| Total Debt/Equity | 0.43 |
| Current Ratio | 17.96 |
| Book Value Per Share | 18.89 |
| 52-Week Change | 40.78 |
| 52-Week High | 78.48 |
| 52-Week Low | 37.02 |
| Moving Average 50 Days | 51.73 |
| Moving Average 200 Days | 55.67 |
| Average Volume | 1.91M |
| Shares Outstanding | 96.45M |
| % Held by Institutions | 85.79 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |